Aligning approaches to rheumatoid arthritis drug development: a comparison of FDA and EMA guidance

The Lancet Rheumatology 2026

View at publisher
Authors: Antonio Ciancio, Andrea Amati, Saviana Gandolfo, Ricardo Grieshaber Bouyer, Ranjeny Thomas, David F L Liew, Guillermo Valenzuela, Laure Gossec, MARIA MANARA, Tae-Hwan Kim, Zoltán Szekanecz, Peter Charles Taylor
+3 more Xavier Mariette, Roberto Caporali, Francesco Ciccia
DOI: 10.1016/s2665-9913(26)00086-x
Cited by: 1
References: 4

Fields of Study & Subjects

Rheumatoid Arthritis Research and Therapies Biosimilars and Bioanalytical Methods Pharmaceutical Economics and Policy

Publication details

Journal / source
The Lancet Rheumatology
Publisher
Elsevier BV
Volume
8
Issue
7
Pages
e563–e575
Publication date
22 June 2026
Language
EN